This study aims to identify and vaccinate participants who may be able to participate in various future clinical trials at Nucleus Network.
The goal is to identify and vaccinate participants who may be able to participate in various future clinical trials at Nucleus Network. These clinical trials will be for complement inhibitor studies, as well as other potential new treatments for other medical conditions.
Call us at 1800 243 733 to discuss your eligibility today!